-
Science Sub-Journal: Antihypertensive drugs can help patients with non-cancerous brain tumors
Time of Update: 2021-07-29
Boston-A new study led by researchers at Massachusetts General Hospital (MGH) and Massachusetts Eye and Ear shows that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2) , This is a genetic disease associated with vestibular schwannoma .
-
Nature Sub-Journal: Reactivation of the "paralyzed" immune system to fatal brain cancer...
Time of Update: 2021-06-06
The study found that it was the cancer-promoting metabolite R-2-HG that interfered with the amino acid metabolism of "cell scavenger" macrophages, and activated the central immune system regulatory molecule aryl hydrocarbon receptor (AHR), thereby causing macrophages to produce Immunosuppressive response.
-
Nature Sub-Journal: Reactivate the "paralyzed" immune system and launch an attack on deadly brain cancer
Time of Update: 2021-06-05
To this end, researchers have developed an innovative treatment to reactivate the "paralyzed" immune system against tumors, that is, to fight gliomas through therapeutic vaccines or immunotherapy.
-
Nature Sub-Journal: Reactivate the "paralyzed" immune system to attack deadly brain cancer
Time of Update: 2021-06-04
The study found that it was the cancer-promoting metabolite R-2-HG that interfered with the amino acid metabolism of "cell scavenger" macrophages, and activated the central immune system regulatory molecule aryl hydrocarbon receptor (AHR), thereby causing macrophages to produce Immunosuppressive response.
-
Science Sub-journal: Old medicine new multi-sclerosis therapy can also cure brain cancer
Time of Update: 2020-06-02
Recently, a team of Professors Of The University of California, San Diego, combined Sanofi's drug, Aubagio (teriflunomide), for the treatment of multiple sclerosis (MS), with the targeted tumor drug B
-
Nature journal: a new method for the treatment of brain metastasis of cancer by continuously
Time of Update: 2019-08-14
August 14, 2019 news / BIOON / - about 15-40% of cancers will metastasize in the central nervous system (CNS), but there is almost no treatment at present Monoclonal antibody based cancer therapy is w
